Related Experiment Videos
Summary
Secret drug pricing creates massive profits for insiders, increasing costs for patients. A single pill with an average wholesale price of $2.66 was sold to pharmacies for only 5 cents.
Area of Science:
- Pharmaceutical economics
- Healthcare policy
- Drug pricing analysis
Background:
- Significant price discrepancies exist in the pharmaceutical market.
- The "average wholesale price" (AWP) may not reflect actual transaction costs.
- Lack of transparency in drug pricing benefits specific stakeholders.
Discussion:
- Investigating the "average wholesale price" (AWP) reveals substantial profit margins.
- Secret pricing strategies lead to inflated costs for patients and the public.
- The pharmaceutical supply chain's opacity facilitates these price variations.
Key Insights:
- One drug, listed at $2.66 AWP, was procured by pharmacies for as little as $0.05 per pill.
- This highlights a potential markup of over 5000% between wholesale and pharmacy acquisition costs.
- Such practices indicate systemic issues in drug price regulation and transparency.
Outlook:
- Policy interventions are needed to ensure fair drug pricing.
- Increased transparency in pharmaceutical pricing could protect patients.
- Further research into drug supply chain economics is warranted.